EXOCUBE BIOTECHNOLOGY LIMITED

Active
Company number 14788549Private limited companyIncorporated 2023

Key figures

£100+0.0%
Net assets 2024/25
+0.0%
Average annual growth 2023/24–2024/25
02550751002023/242024/25

Like most small UK companies, EXOCUBE BIOTECHNOLOGY LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Sector comparison

SIC 72110

Where the company stands among the 3,991 active companies whose first SIC code is 72110 (Research and experimental development on biotechnology).

Company age3.6 years
Younger than 61% · median 5.4 years
Largest in this sector by net assets
  1. BRACCO HORIZONS LIMITED£526.1m
  2. TAURX THERAPEUTICS MANAGEMENT LTD.£470.3m
  3. LABCORP EARLY DEVELOPMENT LABORATORIES LIMITED£317m
  4. JAZZ PHARMACEUTICALS RESEARCH UK LIMITED£289.2m
  5. GENOME RESEARCH LIMITED£273.7m
  6. MODERNA BIOTECH UK LIMITED£236.5m
  7. CURIA (SCOTLAND) LIMITED£183m
  8. ASTEX THERAPEUTICS LIMITED£163.6m
  9. HORIZON DISCOVERY GROUP LIMITED£159.6m
  10. AMGEN LIMITED£134.4m

Positions are approximate. Figures come from each company's latest accounts; money and employee figures are compared only with companies that filed accounts in pounds for a period ending in the last two and a half years and are not dormant. The line on each bar marks the median.

Summary: EXOCUBE BIOTECHNOLOGY LIMITED

What kind of company is it?

EXOCUBE BIOTECHNOLOGY LIMITED is a private limited company registered with Companies House under company number 14788549. It was incorporated on 10 Apr 2023. Its status is active. The registered office is in Sheffield (S3). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110), specialists medical practice activities (86220).

How is the company doing financially?

The latest accounts in the database are for 2024/25 (period ending 30 Apr 2025); the company files dormant company accounts. Net assets were £100, up 0% on the previous year. The company had an average of 0 employees. Figures are available for 2 financial years (2023/24–2024/25).

How does it compare with similar companies?

Compared with 3,991 active companies whose first SIC code is 72110: It is younger than 61% of them (median age 5.4 years).

Who runs and controls the company?

One person with significant control is registered.

When are its next filings due?

The next accounts are due by 31 Jan 2027. The next confirmation statement is due by 3 Feb 2027.

Filed accounts2023/24–2024/25
2023/242024/25
Cash at bank and in hand100—
Total assets——
Total liabilities—100
Net assets / total equity100100
Average number of employees00

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

History

6 events
  1. Financial year 2024/25 endedAccounts: net assets £100, 0 employees
  2. London Regenerative Inst Ltd registered as a person with significant control
  3. Mr Kemal Tiryaki ceased to be a person with significant control
  4. Financial year 2023/24 endedAccounts: net assets £100, 0 employees
  5. Mr Kemal Tiryaki registered as a person with significant control
  6. Company incorporatedPrivate limited company

Dates as recorded at Companies House: incorporation, name changes, officer appointments and resignations, current and former persons with significant control, and the end of each financial year with figures in the database.